Related Experiment Video
Updated: May 28, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Aminaphtone in the treatment of pseudophakic cystoid macular edema: a case report
S Salvatore1, M Bertini, E M Vingolo
1Deparment di Ophthalmology, University La Sapienza, Polo Pontino, A. Fiorini Hospital and Santa Maria Goretti Hospital, Latina, Italy. serena.sal@hotmail.it
Purpose:
Cystoid macular edema (CME) following cataract surgery has been recognized for over 50 years as an important cause of suboptimal post-operative vision. The incidence of CME varies widely, but is likely in the range of 1-2% using modern cataract extraction techniques. We report the case of resolution of post-operative CME after treatment with aminaphtone 75 mg three time a day for one month.
Methods:
A 74-year-old causasian woman presented with reduced vision in the left eye after one month from uneventful cataract phacoemulsification. She underwent a complete ophthalmological examination comprehensive of spectral domain optical coherence tomography (SD-OCT) which showed CME and a central foveal thickness (CFT) of 703 micron. The patient was treated with aminaphtone for one month.
Results:
CME disappeared, the CFT was within normal limits when aminaphtone was ceased, and best corrected visual acuity was 20/20 at the end of the treatment.
Conclusion:
Aminaphtone is a novel proposal in the treatment of pseudophakic cystoid macular edema.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems